Results 251 to 260 of about 1,823,507 (396)

The Role of Surgical Resection Following Primary Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma: A Decision Analysis [PDF]

, 2011
Anu Goenka, Elena B. Elkin, Lauren Shapiro, Nabil P. Rizk, David H. Ilson, Manjit S. Bains, Valerie W. Rusch, Karyn A. Goodman   +7 more
openalex   +1 more source

Tumor‐Derived CDC37 Inhibits Antigen Cross‐Presentation in Dendritic Cells and Impairs Anti‐Tumor Immunity in Breast Cancer

Advanced Science, EarlyView.
Extracellular vesicle (EV)‐packaged CDC37 are released from TMBhiCTLlo breast cancer cells with high CDC37 expression, and internalized into endo/phagosomes of dendritic cells (DCs). Within these compartments, CDC37 locked HSP90–antigen complex, preventing antigen release into the cytosol.
Ruxin Wang, Yunyi Zhang, Xiangyu Meng, Jianli Zhao, Yue Xing, Qian Ouyang, Ning Zhang, Huiping Chen, Nanyan Miao, Erwei Song, Di Huang   +10 more
wiley   +1 more source

Endoscopic full-thickness resection for a submucosal tumor at the esophageal entrance: is closure obligatory? [PDF]

Endoscopy
Li X, Zhang J, Shi M, Liu D.
europepmc   +1 more source

Defining a positive circumferential resection margin in oesophageal cancer and its implications for adjuvant treatment [PDF]

, 2013
Adam, Adamina, Agresti, American Joint Committee on Cancer, Austin, Courrech Staal, Cox, Deeter, Dexter, Gertler, Griffiths, Harvin, International Union Against Cancer, Jemal, Kaplan, Khan, Law, Mapstone, Medical Research Council Oesophageal Cancer Working Group, Pultrum, Quirke, Reid, Rice, Rosenbaum, Royston, Rubin, Sagar, Saha, Salih, Scheepers, Sujendran, van Hagen, Verhage, Wibe   +33 more
core   +1 more source

Human CtIP promotes DNA end resection

Nature, 2007
A. Sartori, C. Lukas, J. Coates, M. Mistrik, Shuang Fu, J. Bartek, R. Baer, J. Lukas, S. Jackson   +8 more
semanticscholar   +1 more source

Interactions of Antibody Drug Conjugate Anti‐Tubulin and Topoisomerase I Inhibitor Payloads with Radiotherapy to Potentiate Immunotherapy

Advanced Science, EarlyView.
Antibody drug conjugates deliver their cytotoxic anti‐tubulin or topoisomerase I inhibitor payloads to tumors through cancer cell receptor targeting. The released drug payloads induce cellular changes that interact with radiotherapy resulting in radiosensitization that improves cancer cell kill and stimulates anti‐tumor immune responses.
Jacqueline Lesperance, Bryan S. Yung, Michael M. Allevato, Marcus M Cheng, Maria F. Camargo, Robert Saddawi‐Konefka, Kanika Dhawan, Ashwyn K. Sharma, Mahsa Mortaja, Sophie Bice, Daniel J. Scanderbeg, Diego Alvarado, Jyoti Mayadev, Ramez N. Eskander, Stephen R. Adams, Pippa F. Cosper, J. Silvio Gutkind, Sunil J. Advani   +17 more
wiley   +1 more source

Extent of reoperation predicts survival in recurrent IDH-wildtype glioblastoma based on institutional data and individual patient data meta analysis. [PDF]

Discov Oncol
Basaran AE, Wellkisch AC, Güresir E, Wach J.   +3 more
europepmc   +1 more source

The carotid body as a therapeutic target for the treatment of sympathetically mediated diseases [PDF]

, 2013
Abdala, Ana P, Burchell, Amy, Engleman, Zoar J, Fudim, Marat, Gourine, Alexander V, Hart, Emma C J, Lobo, Mel, Marina, Nepthali, McBryde, Fiona D, Nightingale, Angus, Patel, Nik, Paton, Julian F R, Ratcliffe, Laura E K, Sobotka, Paul A   +13 more
core   +1 more source

Ileal resection/dysfunction in childhood predisposes to lithogenic bile only after puberty

, 1992
James E. Heubi, Nancy C. O’Connell, Kenneth D.R. Setchell   +2 more
openalex   +1 more source

Intention‐to‐treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation

Hepatology, 1999
J. Llovet, J. Fuster, J. Bruix
semanticscholar   +1 more source